Anti-cancer Effects of Glypican-3 on Huh-7 Hepatocellular Carcinoma Cells

Aim: Previous studies have suggested Glypican-3 (GPC3) could be a valuable diagnostic marker for hepatocellular carcinoma. This study examined the effects of overexpression of GPC3 on Huh-7 hepatoma cells. Methods: We constructed a recombinant plasmid vector pcDNA3.1 (+)-GPC3 for GPC3 overexpression studies in Huh-7 cells. RT-PCR and Western blotting were used to confirm GPC3 gene expression. Cell proliferation was evaluated by 5-ethynyl-2-deoxyuridine (EdU) incorporation assay. Cell cycle progression and apoptosis were determined by flow cytometry using propidium iodide (PI) and Annexin V-FITC/PI staining, respectively. Cell migration and invasion were examined by Boyden Transewll and Matrigel assays. Results: GPC3 overexpression effectively inhibited proliferation, induced cell cycle arrest at S phase and increased apoptosis in Huh-7 cells. Furthermore, GPC3 overexpression significantly inhibited the migration and invasion ability of Huh-7 cells. Conclusion: Our results demonstrate that GPC3 could be a new therapeutic target for hepatocellular carcinoma.


Introduction
Hepatocellular carcinoma is the third leading cause of cancerrelated death in the world [1]. The outcome of patients with hepatocellular carcinoma is very poor with 5-year survival rate is less than 10-15% [2,3]. Several clinic pathological features, such as, poorly differentiated phenotype and portal venous invasion, have suggested to contribute to the poor prognosis in hepatocellular carcinoma patients. The underlying molecular mechanisms of the development of hepatocellular carcinoma remains elusive.
Glypican-3 (GPC3) is a member of the protein glycan family with a tissue-specific expression [4]. They are released from cell surface and functional to regulate the cell signaling of migration, proliferation and cell survival [5,6]. Previous studies have suggested that GPC3 is a valuable diagnostic biomarker for hepatocellular carcinoma [7,8]. Glypicans regulate several signaling pathways such as Wnts, hedgehogs, fibroblast growth factors which could exert stimulatory or inhibitory effects on cells. In cells predominately controlled by hedgehogs signaling, GPC3 inhibits cell proliferation, whereas in cell predominately controlled by Wnt signaling pathway, GPC3 stimulates cell proliferation [9][10][11]. GPC-3 have shown to be overexpressed in hepatocellular carcinoma [12]. Silencing GPC3 in hepatocellular carcinoma cells inhibited cell proliferation and increased cell apoptosis. Moreover, another study shows that suppression of GPC3 inhibits cell proliferation and cell cycle progression in HepG2 cells but no significant effect in the Huh-7 cells [9]. However, the potential effect of overexpression of GPC3 in hepatocellular carcinoma remains unclear.
In this study, we overexpressed GPC3 in Huh-7 cells by using the recombinant plasmid pcDNA3.1 (+)-GPC3 to analyze the effects of GPC3 overexpression on hepatocellular carcinoma.

Real time RT-PCR analysis of GPC3 expression
Real-time PCR was carried out on ABI 7900HT real-time PCR system 7900 (USA) using the PrimeScrip RT-PCR Kit (Takara, Japan) as previously reported [13]. Briefly, after 48 h of transfection, the total RNAs were extracted from control, negative control and Huh-7-PGC cells by using the Trizol reagent (Life Technologies, USA) according to the manufacturer's instruction. Then the RNAs were converted into cDNA using specific primers (forward, 5'-AGAAACCTTATCCAGCCGAAGAA-3'; reverse, 5'-TGGGTCCAACTACTAAGCT-3') and reverse transcription kit. GAPDH was used as an internal control. The relative gene expression was determined by using the 2-ΔΔCt method. Experiment was repeated for three times.

Proliferation assay of Huh-7 cells
The Huh-7 cell proliferation was evaluated by using 5-ethynyl-2deoxyuridine (EdU) incorporation assay [14]. Briefly, after 72 hr of transfection, cells were cultured in fresh complete culture medium (DMEM supplemented with 10% fetal bovine serum (FBS) for 12 hr, followed by incubation with medium supplemented with 50 mM EdU (1:1000) (Ribobio, Guangzhou, China) for 2 hr. Then, cells were fixed for 15 min at room temperature (RT), permeabilized with 0.5% Triton X-100 in PBS for 20 min, and incubated with apollo® fluorescent dye (Invitrogen, Carlsbad, CA) for 30 min at RT in the dark. 4', 6-Diamidino-2-Phenylindole (DAPI) (Invitrogen, Carlsbad, CA) was used to counterstain the nucleus. Images were taken under a fluorescent microscope (Olympus, Japan)at three random fields. The percentage of EdU-positive cells was calculated as: EdU+ cells (%) = EdU+ cells / DAPI+ cells x 100%. The experiment was performed for three times.

Cell cycle and apoptosis analyses of Huh-7 cells
Cell cycle progression of Huh-7 cells was determined by flow cytometry using propidium iodide (PI) [15]. Briefly, after 72hr of transfection, Huh-7 cells were trypsinized, fixed with cold 75% ethanol for 1 hr and centrifuged. Then the cell pellet was resuspended and incubated with PI (50 µg/ml; Beyotime, China) containing RNaseA (0.1 mg/ml) in PBS for 30 min at RT in the dark. Sample was analyzed using a FACS can flow cytometer with Cell Quest software (Becton Dickinson, NJ, USA).
The apoptosis assay of Huh-7 cells was conducted by using Annexin V-FITC/PI apoptosis detection kit as previously described [16]. Briefly, after 72hr of transfection, Huh-7 cells were washed, incubated with Annexin V-FITC and PI staining solution (Becton Dickinson, USA) for 20 min at RT in the dark and then analyzed by flow cytometer. All experiments were performed for three times.

Migration and invasion assays of Huh-7 cells
The migration and invasion assays of Huh-7 cells was carried out by using Boyden chamber as previously described [17]. For cell invasion assay, the porous membrane of the top insert (8.0 µm pore size, BD Biosciences) was coated with matrigel (40 µl, BD Bioscience, USA) for 2-3 h at 37˚C. After 72 h of transfection, Huh-7 cells (100 µl, 1×105/ well of a 24-well plate) were replaced with fresh serum-free DMEM and seeded on to the top insert or matrigel-coated top insert. Then, DMEM supplemented 10% FBS (600 µl) was added into the bottom well. After 24 h incubation at 37˚C, cells migrated through the porous membrane to bottom wells were fixed in 75% ethanol for 15 min, stained with crystal violet solution (Sigma-Aldrich, USA), and cells invaded through matrigel and membrane to bottom well were directly counted under an inverted microscope, respectively. All experiments were repeated for three times.

Western blot analysis of GPC3 expression
After 72 hr transfection, proteins were collected from different groups by using lysis buffer as previously described [13]. The protein lysates were then be electrophoresed through SDS-PAGE gel and transferred onto PVDF membranes. The membranes were blocked and probed with primary antibodies against GPC3 (Santa cruz, USA) or GAPDH (Santa cruz, USA) followed by incubation with HRPconjugated IgG. Blots were then developed with enhanced chemiluminescence developing solutions and quantified under Image J software.

Statistical Analysis
Data were presented as the mean ± SD (standard deviation). Comparisons among multiple groups were analyzed by ANOVA using the SPSS 17.0 software and the comparison between two groups was analyzed by Student's t-test. P<0.05 was considered statistically significant.

Results mRNA and protein expression of GPC3 in Huh-7 cells were increased after plasmid pcDNA3.1 (+)-GPC3 transfection
The real time RT-PCR results showed that the expression level of GPC3 in the Huh-7 cells transfected with GPC3 was significantly higher than that in control or mock groups ( Figure 1A) (P<0.01, control or mock Vs. Huh-7-GPC3). There is no significant difference between control and mock groups (P>0.05, control vs. mock). The protein expression level of GPC3 was increased in Huh-7-GPC3 cells as revealed by western blot analysis ( Figure 1B and 1C) (P<0.05, control or mock Vs. Huh-7-GPC3). Similarly, there is no difference of GPC3 protein expression between control and mock groups (P>0.05, control Vs. mock).

Overexpression of GPC3 inhibited the proliferation of Huh-7 cells
The effect of GPC3 overexpression on the proliferation of Huh-7 cells was evaluated by EdU incorporation assay. As shown in Figure 2, the percentage of EdU-positive cells was significantly decreased in Huh-7-GPC3 group as compared to that in control and mock groups (P<0.05, 90.1 ± 5.9%, 91.0 ± 2.5%, and 81.06 ± 3.6% for control, mock and Huh-7-GPC3, respectively; control or mock Vs. Huh-7-GPC3). And there was no significant difference of EdU-positive cells between control and mock groups (P>0.05, control Vs. mock). These results indicated that overexpression of GPC3 in Huh-7 cells could inhibit cell proliferation.

Overexpression of GPC3 inhibited Huh-7 cell cycle progression
As shown in Figure 3, the flow cytometric results showed that there was a significant increase of S phase Huh-7 cells in GPC3 transfection group (P<0.05, control or mock Vs. Huh-7-GPC3). In addition, a concomitant increase of Huh-7 cells in sub G1 phase and reduction of Huh-7 cells in G2/M phase were observed in the GPC3 transfection group (P<0.05, control or mock Vs. Huh-7-GPC3 ). And the proportion of cells at the G1 phase was not significantly changed.

Overexpression of GPC3 increased apoptosis of Huh-7 cells
To investigate the potential effect of GPC3 overexpression on cellular apoptosis, the treated cells were stained with annexin V-FITC/PI and analyzed by flow cytometry. We found that there were higher percentages of both early stage apoptotic cells and late stage apoptosis and necrotic cells in the Huh-7-GPC3 groups when compared to those in control or mock groups (P<0.05, control or mock Vs. Huh-7-GPC3; Figure 4A and 4B).

Overexpression of GPC3 decreased the migration and invasion abilities of Huh-7 cells
Our results showed that Huh-7 cell migration ability was significantly suppressed in Huh-7-GPC3 cells when compared to that in control or mock groups (P<0.01, control or mock Vs. Huh-7-GPC3; Figure 5A). The percentage of cells passed through the membrane of the inserters to the bottom wells was reduced from 47.3 ± 7.7% Citation: Wen J, Wen X, Wang J, Shu Y, Qiu Z, et al. (2014) Anti-cancer Effects of Glypican-3 on Huh-7 Hepatocellular Carcinoma Cells. J Cell (control group) or 40.9 ± 10.1% (mock group) to 14.0 ± 5.2% (Huh-7-GPC3 group). These results supported that GPC3 overexpression could effectively inhibit cell migration.  The results of invasion assay showed that GPC3 overexpression significantly lowered the invasion activity of Huh-7 cells as compared to those in control or mock groups (P<0.05, control or mock Vs. Huh-7-GPC3; Figure 5B). The percentage of cells invaded through the matrigel and membrane to the bottom wells was apparently decreased from 7.9 ± 1.5% (control group) or 10.6 ± 4.2% (mock group) to 4.9 ± 1.2% (Huh-7-GPC3 group). These results showed that GPC3 overexpression could effectively suppress GPC3 cell invasion.

Discussion
In the present study, we found that overexpression of GPC3 in Huh-7 cells can inhibit cell proliferation, induce apoptosis, arrest cell cycle progression at the S phase, and suppress Huh-7 cell migration and invasion. GPC3 is a member of the glypican family that plays an important role in modulating cell growth, migration, invasion and cell cycle progression [18,19]. The protein expression of GPC3 is up-regulated in hepatocellular carcinoma [12]. Interestingly, we found that GPC3 overexpression could effectively inhibiting cell proliferation as revealed by using EdU staining in the Huh-7 cells. We speculate that the inhibition of cell proliferation resulted from cell cycle arrest, because cell cycle checkpoints are critical intersections for cell growth. In order to validate our hypothesis regarding to the suppression of cell proliferation is associated with cell cycle arrest, we determined Huh-7 cell cycle progression by flow cytometry. Our results revealed that overexpression of GPC3 arrested Huh-7 cells at S phase, decreased the percentage of Huh-7 cells at G2/M phase, and concurrently increased cell apoptosis and necrosis at sub G1 phase. Our cell proliferation data are in line with the cell cycle results. For proliferation assay, the EdU positive cells were measured after an additional 12 hrs culture following GPC3 overexpression. Whereas, for cell cycle assay, PI staining was performed immediately following GPC3 overexpression. The EdU experiment revealed a decrease in the percentage of S phase cells, suggesting the inhibitive effect of GPC3 on cell proliferation. For the PI experiment, we observed an increase in the percentage of S phase cells. This could be interpreted by S phase cell accumulation because we found that there was a decrease in percentage of G2/M phase cells, indicating that GPC3 prevents cells enter into G2/M phase. These data generated from different experiment protocols together suggest that the growth-inhibitory effects of GPC3 overexpression could result from changes in the cell cycle.
Several previous studies have suggested the involvement of GPC3 in hepatocellular carcinoma [12,20,21]. Of note, silencing GPC3 in hepatocellular carcinoma cells has been shown to inhibit cell proliferation and increase cell apoptosis [21]. Moreover, a study has shown that suppression of GPC3 inhibits cell proliferation and cell cycle progression in HepG2 cells but no significant effect in the Huh-7 cells [9]. Such a discrepancy could exist because of different cell lines as well as experimental conditions applied for the studies. Nevertheless, the more underlying mechanisms require further investigation.
Apoptosis induction is considered as a very useful approach for cancer therapy. Many studies have indicated that GPC3 plays an important role in regulating cell survival [18,19]. A previous report showed that murine mammary tumor LM3 cells overexpressing GPC3 were much more sensitive to apoptosis induction [22]. Consistently, we observed that Huh-7 cells transfected with GPC3 plasmid had a increased percentage of apoptotic rate in this study.
It is well-known that cell migration and invasion play a crucial role in cancer [23]. And proteolytical disruption of basement membrane is a key step involved in the migration and invasion processes. In the present study, we examined the migration and invasion abilities of the Huh-7 cells trasnfected with GPC3 plasmid. Our results showed that overexpression of GPC3 in Huh-7 cells significantly inhibited cell migration and invasion. Further studies will be performed to clarify the mechanisms underlying the biologic effects of GPC3 on Huh-7 cells.
In conclusion, our results demonstrate that the overexpression of GPC3 in Huh-7 cells inhibits cell proliferation, induces apoptosis associated with arresting cell cycle progression at the S phase, and suppresses cell migration and invasion. These data indicate the diagnostic and therapeutic potential of GPC3 in hepatocellular carcinoma patients.